Vaccine – What needs more trust?

21.02.2021


Clean compressed air in vaccine production

Vaccine – What needs more trust?

„I am pleased that AQUAAIR can also help with the production of vaccines.” – Marco Lodni, Managing Partner


mRNA-1273

The COVID-19 vaccine from Moderna

The American biotechnology company „ModeRNA“ develops medicines based on messenger RNA (mRNA).

In March 2020, Moderna was the first company worldwide to receive approval for a clinical trial of its SARS-CoV-2 vaccine candidate mRNA-1273.

On December 18, 2020, the U.S. Food and Drug Administration (FDA) granted the Moderna COVID-19 vaccine an emergency approval.


Rated priority

Production and distribution of the vaccine

By order of the US Department of Defense, the production and distribution of the Modena COVID-19 vaccine was prioritized:

Every company and institution directly or indirectly involved in the production and distribution of the vaccine is urged to treat the task at hand with high priority and, above all, to keep to the demanding schedule.

In January 2021, AQUAAIR received a prioritized order to supply the production of the Moderna vaccine with clean compressed air as quickly as possible. – The second order followed in February 2021 …


When it really matters

Clean compressed air from AQUAAIR

As an OEM of Dräger compressed air systems, AQUAAIR is a leader in supplying hospitals with truly clean compressed air.

When it really matters: Clean compressed air from AQUAAIR meets your highest demands!

We at AQUAAIR say thank you for the trust placed in us and hope that the vaccine will soon bring our normal life back.

Learn more about AQUAAIR

Back to the References